Latest by Donna M. Kaminski, D.O., M.P.H.

Promo Image

New Hope for a Cure

Since the earliest days of the epidemic, people have hoped for a cure and a vaccine. In 1984, when the discovery of HIV was confirmed, then-Secretary of Health and Human Services Margaret Heckler famously announced that a vaccine would be ready for t...

HIV and Inflammation: A New Threat Img

HIV and Inflammation: A New Threat

Introduction What Is Inflammation? Inflammatory Markers and Mortality Aging Before Your Time? Conclusion


Traditionally, it was thought that the natural course of HIV included a period of latency -- a time when the virus was i...

Promo Image

Race Troubles: Why Do African-Americans With HIV Fare Worse?

Since I began working as an HIV treatment educator in New York City, I've seen the faces of those I served change. As those faces grew to include primarily African-Americans and Latinos, I found myself both inspired and moved by my clients.

As a who...

Promo Image
Hepatitis C

Hepatitis C: A Closer Look

Many people living with HIV must deal with not only one virus, but also with a co-traveler: hepatitis C virus (HCV), which infects liver cells. For some, the liver is only slightly damaged since it is able to make new cells and bounce back. But for o...

Promo Image

Peering Into the Pipeline: New Drug Candidates

As I further my medical training, I find that the management of HIV remains intricate, requiring both an increasing understanding of the disease and a growing tool set. So many resources come into play when deciding on a treatment regimen, including ...

Promo Image

Integrase Inhibitors: The Next Wave?

In 2006, the ten-year anniversary of HAART (highly active antiretroviral therapy), we have over 20 HIV medications in our arsenal. But the need for a "new wave" of HIV medications that can target new steps in HIV's life cycle remains strong. HIV can ...

Promo Image

Entry Inhibitors: The Bouncers at the Door

T-20 T-1249 SCH-C PRO 542

There is good news on the horizon for people whose HIV is resistant to many currently approved antiretrovirals -- the development of a new class of anti-HIV drugs called entry inhibitors. Entry inhibitors have shown...